http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

高效液相色谱法测人血浆中阿魏酸哌嗪浓度及其药动学研究

袁桂艳*, 王本杰, 魏春敏, 刘焕君, 郭瑞臣**

  

  1. 山东大学齐鲁医院临床药理研究所, 山东 济南 250012
  • 收稿日期:2006-03-19 修回日期:2006-11-10 出版日期:2006-12-15 发布日期:2006-12-15
  • 通讯作者: 袁桂艳*,郭瑞臣**

Determination of Piperazine Ferulate in Human Plasma by HPLC and Its Pharmacokinetic Study

YUAN Gui-yan*, WANG Ben-jie, WEI Chun-min, LIU Huan-jun, GUO Rui-chen**   

  1. Institute of Clinical Pharmacology, Qilu Hospital of Shandong University, Jinan 250012, China 2004 Master degree student, School of Pharmacy, Shandong University
  • Received:2006-03-19 Revised:2006-11-10 Online:2006-12-15 Published:2006-12-15
  • Contact: YUAN Gui-yan*, GUO Rui-chen**

摘要: 目的 建立灵敏的HPLC法测定人血浆中阿魏酸哌嗪浓度, 并进行其健康志愿者药动学研究。方法 采用液-液萃取, C18柱分离,0.1%冰醋酸-甲醇(60:40, V/V)洗脱, 紫外波长310 nm检测。20名男性健康志愿者口服200 mg阿魏酸哌嗪分散片, 测定阿魏酸哌嗪浓度, DAS 2.0软件计算主要药动学参数。结果 阿魏酸哌嗪线性范围为53000 ng·mL-1, 提取回收率约为70%, 日内和日间变异分别小于8.9%10.1%。阿魏酸哌嗪主要药动学参数分别为: Cmax1144.487 ± 599.839 ng·mL-1, Tmax 0.37 ± 0.08 h, t1/2 0.805 ± 0.298 h, AUC0-4 604.019 ± 232.874 ng·mL-1·h, AUC0-∞ 611.778 ± 234.147 ng·mL-1·h结论 建立的HPLC法快速,灵敏,适合阿魏酸哌嗪药动学研究及大样本测定。

关键词: 阿魏酸哌嗪分散片, 阿魏酸哌嗪分散片, 阿魏酸哌嗪分散片, 药动学, 药动学, 药动学, 高效液相色谱, 高效液相色谱, 高效液相色谱

Abstract: Aim To establish a sensitive HPLC method for determination of piperazine ferulate and to study its pharmacokinetics in healthy volunteers. Methods Piperazine ferulate was separated on a Shimadzu C18 column with acetic acid (0.1%)-methanol (60:40, V/V) as mobile phase after liquid-liquid extraction, and detection was performed at 310 nm. Piperazine ferulate pharmacokinetic parameters after a single oral dose of 200 mg of piperazine ferulate dispersible tablets in 20 healthy male volunteers were calculated and evaluated using DAS 2.0. Results The linear range of the calibration curve for piperazine ferulate was 5 - 3 000 ng·mL-1, and the absolute recovery was about 70%. Intra-day RSD and inter-day RSD were less than 8.9% and 10.1%, respectively. The pharmacokinetic parameters, as Cmax, Tmax , t1/2, AUC0 -4, and AUC0-∞, after a single oral dose of piperazine ferulate dispersible tablets were 1144.487 ± 599.839 ng·mL-1, 0.373 ± 0.08 h, 0.805 ± 0.298 h, 604.01 ± 232.874 ng·mL-1·h, and 611.778 ± 234.147 ng·mL-1 ·h, respectively. Conclusion The HPLC method for determining piperazine ferulate concentration in plasma is rapid, sensitive and suitable for pharmacokinetic studies and routine determination of large samples.

Key words: piperazine ferulate dispersible tablet, piperazine ferulate dispersible tablet, pharmacokinetics, pharmacokinetics, HPLC, HPLC

中图分类号: 

Supporting:

*2004 Master degree student, School of Pharmacy, Shandong University
**Corresponding author. Tel.: 86-531-82169636